Lv21
150 积分 2023-05-25 加入
[Guideline for HER2 testing in breast cancer (2024 version)]
24天前
已完结
DNA damage and the balance between survival and death in cancer biology
5个月前
已完结
SF3A2 promotes progression and cisplatin resistance in triple-negative breast cancer via alternative splicing of MKRN1
11个月前
已关闭
PARPi treatment enhances radiotherapy-induced ferroptosis and antitumor immune responses via the cGAS signaling pathway in colorectal cancer
1年前
已完结
Response-guided neoadjuvant sacituzumab govitecan for localized triple negative breast cancer: results from the NeoSTAR trial
1年前
已完结
Targeting DNA damage response pathways in cancer
1年前
已完结
Metastasis prevention: How to catch metastatic seeds
1年前
已完结
皖公网安备34019202002308
